Anagrelide is an oral thrombocytopenic agent that belongs to the class of phosphodiesterase 3 (PDE3) inhibitors.
Authentic
Guarantee
Fast Delivery
Privacy The U.S. FDA has approved Agrylin (anagrelide) for the treatment of thrombocytosis associated with essential thrombocythemia and polycythemia vera. It···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 69
Copyright2024@ BIGBEAR All right reserved BIGBEAR



